EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma

Leukemia. 2023 Sep;37(9):1925-1928. doi: 10.1038/s41375-023-01983-0. Epub 2023 Aug 2.

Djamila Chemlal^#^{1

2}, Emmanuel Varlet^#², Amelie Machura¹, Sara Ovejero^{2

3}, Guilhem Requirand³, Nicolas Robert³, Guillaume Cartron^{4

5}, Elina Alaterre², Caroline Bret^{2

3

5}, Laure Vincent⁴, Charles Herbaux^{2

4

5}, Giacomo Cavalli², Angélique Bruyer¹, Hugues De Boussac¹, Jerome Moreaux^{6

7

8

9}

¹ Diag2Tec, Montpellier, France.
² Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France.
³ Department of Biological Hematology, CHU Montpellier, Montpellier, France.
⁴ Department of Clinical Hematology, CHU Montpellier, Montpellier, France.
⁵ University of Montpellier, UFR Medicine, Montpellier, France.
⁶ Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France. [email protected].
⁷ Department of Biological Hematology, CHU Montpellier, Montpellier, France. [email protected].
⁸ University of Montpellier, UFR Medicine, Montpellier, France. [email protected].
⁹ Institut Universitaire de France (IUF), Paris, France. [email protected].

^# Contributed equally.

No abstract available

Publication types